Dot1l modulates the senescence-associated secretory phenotype through epigenetic regulation of il1a

Kelly E. Leon, Raquel Buj, Elizabeth Lesko, Erika S. Dahl, Chi Wei Chen, Naveen Kumar Tangudu, Yuka Imamura-Kawasawa, Andrew V. Kossenkov, Ryanp Hobbs, Katherine M. Aird

Research output: Contribution to journalArticlepeer-review

27 Scopus citations


Oncogene-induced senescence (OIS) is a stable cell cycle arrest that occurs in normal cells upon oncogene activation. Cells undergoing OIS express a wide variety of secreted factors that affect the senescent microenvironment termed the senescence-associated secretory phenotype (SASP), which is beneficial or detrimental in a context-dependent manner. OIS cells are also characterized by marked epigenetic changes. We globally assessed histone modifications of OIS cells and discovered an increase in the active histone marks H3K79me2/3. The H3K79 methyltransferase disruptor of telomeric silencing 1-like (DOT1L) was necessary and sufficient for increased H3K79me2/3 occupancy at the IL1A gene locus, but not other SASP genes, and was downstream of STING. Modulating DOT1L expression did not affect the cell cycle arrest. Together, our studies establish DOT1L as an epigenetic regulator of the SASP, whose expression is uncoupled from the senescence-associated cell cycle arrest, providing a potential strategy to inhibit the negative side effects of senescence while maintaining the beneficial inhibition of proliferation.

Original languageEnglish (US)
Article numbere202008101
JournalJournal of Cell Biology
Issue number8
StatePublished - Aug 2 2021

All Science Journal Classification (ASJC) codes

  • Cell Biology


Dive into the research topics of 'Dot1l modulates the senescence-associated secretory phenotype through epigenetic regulation of il1a'. Together they form a unique fingerprint.

Cite this